alpha4-beta1/alpha4-beta7 antagonists (Roche)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namealpha4-beta1/alpha4-beta7 antagonists (Roche)
Drug Alias Namealpha4-beta1/alpha4-beta7 antagonist prodrugs (Roche)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonistsIntegrin alpha-4/beta-7 inhibitors
TargetsIntegrin alpha-4/beta-1Integrin alpha-4/beta-7
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ag
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A